Exagen Financial Health
Financial Health criteria checks 6/6
Exagen has a total shareholder equity of $42.5M and total debt of $29.0M, which brings its debt-to-equity ratio to 68.2%. Its total assets and total liabilities are $86.2M and $43.8M respectively.
Key information
68.2%
Debt to equity ratio
US$28.97m
Debt
| Interest coverage ratio | n/a |
| Cash | US$62.39m |
| Equity | US$42.46m |
| Total liabilities | US$43.76m |
| Total assets | US$86.22m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: E08A's short term assets ($72.6M) exceed its short term liabilities ($9.6M).
Long Term Liabilities: E08A's short term assets ($72.6M) exceed its long term liabilities ($34.1M).
Debt to Equity History and Analysis
Debt Level: E08A has more cash than its total debt.
Reducing Debt: E08A had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: E08A has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: E08A has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 34.5% each year.